OraSure Technologies Acquires Sherlock Biosciences

January 15, 2025
December 19, 2024 at 4:02 PM EST

BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers.

Read this press release article.